Molecular Diagnosis & Therapy

, Volume 23, Issue 6, pp 813–814 | Cite as

Authors’ Reply to Wang and Huang: “Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-analysis”

  • Rama JayarajEmail author
  • Sabapathi Nadana
  • Shanthi Sabarimurugan
  • Madhav Madurantakam Royam
  • Chellan Kumarasamy
  • Xingzhi Xu
  • Gaixia Xu
Letter to the Editor


Compliance with Ethical Standards

Conflict of interest

The authors (RJ, NS, SS, MRM, CK, XX, and GX) declare that there is no conflict of interests regarding the publication of this paper.


No sources of funding were used in this work.


  1. 1.
    Wang B, Huang Y. Comment on “Prognostic significance of FOXC1 in various cancers: a systematic review and meta-analysis”. Mol Diagn Ther. 2019. Scholar
  2. 2.
    Sabapathi N, Sabarimurugan S, Royam MM, Kumarasamy C, Xu X, Xu G, et al. Prognostic significance of FOXC1 in various cancers: a systematic review and meta-analysis. Mol Diag Ther. 2019. Scholar
  3. 3.
    Huang L, Huang Z, Fan Y, He L, Ye M, Shi K, et al. FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway. Am J Transl Res. 2017;9(3):1297.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Xu YL, Yao R, Li J, Zhou YD, Mao F, Pan B, et al. FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer. Cancer Chemother Pharmacol. 2017;79(6):1205–13.CrossRefGoogle Scholar
  5. 5.
    GetData Graph Digitizer. 2019 [cited 2019. Accessed 30 Jan 2019.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.College of Health and Human SciencesCharles Darwin UniversityDarwinAustralia
  2. 2.Guangdong Key Laboratory for Genome Stability and Disease PreventionShenzhen University School of MedicineShenzhenChina
  3. 3.Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic EngineeringShenzhen UniversityShenzhenChina
  4. 4.CHIRI, School of Pharmacy and Biological Research, Faculty of Health SciencesCurtin UniversityPerthAustralia
  5. 5.School of Biosciences and TechnologyVellore Institute of Technology (VIT)VelloreIndia
  6. 6.University of AdelaideAdelaideAustralia

Personalised recommendations